Arcutis Biotherapeutics Inc.
ARQT
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
24.83
USD
-0.03
(-0.12%)
Optionable: Yes Market Cap: 1,464 M 90-day average vol: 580,372
Previous close: 24.86 Open: 24.96 Bid: 24.82 Ask: 24.82
52 week range
13.59 26.13
Last updated: Friday 12th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Chart
News
Arcutis to Present at Upcoming Investor Conference
Yahoo Finance 3/2/2022
Arcutis Biotherapeutics GAAP EPS of -$1.42 beats by $0.18
Seeking Alpha 2/22/2022
Arcutis Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Yahoo Finance 2/22/2022
Arcutis Completes Enrollment of STRATUM Pivotal Phase 3 Trial of Topical Roflumilast Foam in Individuals with Seborrheic Dermatitis
Yahoo Finance 2/1/2022
10 Small-Cap Stocks to Buy According to Billionaire Steve Cohen
Yahoo Finance 1/10/2022
Arcutis Biotherapeutics Inc Insiders are Selling. Investors Should Take Notice
Yahoo Finance 12/28/2021
Arcutis Secures $225M Debt Financing To Fund Potential Launch Of Roflumilast
Yahoo Finance 12/23/2021
Arcutis' Roflumilast Cream For Psoriasis Goes Under FDA Review
Yahoo Finance 12/23/2021
Arcutis Bio secures $225M in non-dilutive debt financing from SLR Capital
Seeking Alpha 12/23/2021
Arcutis Biotherapeutics Secures $225 Million in Non-Dilutive Debt Financing from SLR Capital Partners
Yahoo Finance 12/23/2021
FDA accepts Arcutis Bio's new drug application for roflumilast cream for psoriasis
Seeking Alpha 12/23/2021
FDA Accepts Arcutis Biotherapeutics’ New Drug Application for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis
Yahoo Finance 12/22/2021
Arcutis Appoints Mas Matsuda as General Counsel and Corporate Secretary
Yahoo Finance 12/16/2021
Arcutis Announces Data Comparing the Vehicle in Investigational Roflumilast Cream Against a Commercial Ceramide-Containing Moisturizing Cream
Yahoo Finance 12/13/2021
Arcutis Biotherapeutics EPS beats by $0.11
Seeking Alpha 11/4/2021
Arcutis Announces Third Quarter 2021 Financial Results and Provides Business Update
Yahoo Finance 11/4/2021
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!